Results 151 to 160 of about 18,944 (198)

Clinical outcomes of teicoplanin use in the OPAT setting [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2020
Teicoplanin possesses several convenient properties for use in the delivery of outpatient parenteral antimicrobial therapy (OPAT) services. However, its use is not widespread and data on its efficacy in the OPAT setting are limited.
Gabriele Pollara   +2 more
exaly   +3 more sources

Pharmacokinetics of Teicoplanin

Chemotherapy, 2009
We investigated the pharmacokinetic properties of teicoplanin, after 200 mg i.v. and i.m. administration in 10 healthy male subjects by assuming a three-compartment open model with elimination from the central compartment. The mean peak plasma level was 7.16 μg/ml reached after 2.26 h. The half-life, the plasma and renal clearances, evaluated from i.v.
RIPA, Sandro   +3 more
openaire   +3 more sources

Teicoplanin

Reactions Weekly, 2018
C. Vidal, W.-R. Külpmann
  +5 more sources

Teicoplanin

Reactions Weekly, 2021
openaire   +2 more sources

Home - About - Disclaimer - Privacy